Efficacy of Hepatic Arterial Infusion Chemotherapy and Radiofrequency Ablation against Hepatocellular Carcinoma Refractory to Transarterial Chemoembolization and Vascular Variation: A Case Study / 고신대학교의과대학학술지
Kosin Medical Journal
;
: 161-168, 2021.
Article
in English
| WPRIM
| ID: wpr-918383
ABSTRACT
Transarterial chemoembolization is often the first-line treatment for multiple hepatocellular carcinomas. However, hepatic arterial infusion chemotherapy is a treatment option for hepatocellular carcinoma refractory to multiple sessions of transarterial chemoembolization. Hepatic arterial infusion chemotherapy requires implantation of an appropriate port into the hepatic artery. However, it may be impossible to implant a port due to hepatic artery variation. We report a case of hepatocellular carcinoma refractory to transarterial chemoembolization and hepatic artery variation treated successfully with hepatic arterial infusion chemotherapy and radiofrequency ablation with complete response after implantation of ports in both liver lobes.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
English
Journal:
Kosin Medical Journal
Year:
2021
Type:
Article
Similar
MEDLINE
...
LILACS
LIS